MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2022 Evaluate
The revenue slipped marginally during the December 2021 quarter. A decline of about Rs. 6879.00 millions was observed as compared to Rs. 7203.00 millions during the corresponding quarter last year.The Company's Net profit for the December 2021 quarter have declined marginally to Rs. 904.00  millions as against Rs. 1230.00 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 1435.00 millions from 1832.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 6879.00 7203.00 -4.50 29566.00 29019.00 1.88 29566.00 29019.00 1.88
Other Income 163.00 162.00 0.62 744.00 898.00 -17.15 744.00 898.00 -17.15
PBIDT 1435.00 1832.00 -21.67 8369.00 8029.00 4.23 8369.00 8029.00 4.23
Interest 4.00 4.00 0.00 18.00 18.00 0.00 18.00 18.00 0.00
PBDT 1431.00 1906.00 -24.92 13243.00 7594.00 74.39 13243.00 7594.00 74.39
Depreciation 109.00 204.00 -46.57 667.00 822.00 -18.86 667.00 822.00 -18.86
PBT 1322.00 1702.00 -22.33 12576.00 6772.00 85.71 12576.00 6772.00 85.71
TAX 418.00 472.00 -11.44 3132.00 1996.00 56.91 3132.00 1996.00 56.91
Deferred Tax -12.00 5.00 -340.00 -228.00 -114.00 100.00 -228.00 -114.00 100.00
PAT 904.00 1230.00 -26.50 9444.00 4776.00 97.74 9444.00 4776.00 97.74
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 20.86 25.43 -17.98 28.31 27.67 2.31 28.31 27.67 2.31
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..